Central Nervous System Disease
9
2
2
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.1%
1 terminated out of 9 trials
80.0%
-6.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
Validation on Clinical Adaptability of the Foundation Model Specific to Neuroimaging Diagnosis
Long-term Brain Stimulation of the Motor Ventral Thalamus (VOP/VIM) to Improve Motor Function
An Explainable Neuroradiologist Artificial Intelligence Assistance System for Brain CT and MRI
Bilateral Pallidal Stimulation in Patients With Advanced Parkinson's Disease-LATESTIM
Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis
Influence of Area of Brain Damage on Brain Reorganization After Chronic Stroke
Retrospective Study of MRI in Pediatric Patients
Brain Processing of Language Meanings